Survivors Diagnosed at Young Age More Likely to be Financially Dependent

Share this content:
Cancer therapy costs are a factor in successful treatment.
Cancer therapy costs are a factor in successful treatment.

Survivors of cancer diagnosed at a young age in Norway were more likely to be financially dependent and unemployed than individuals without cancer, a study published in Cancer has shown.1

The number of young cancer continues to rise, but there are limited data on the impact of cancer on socioeconomic outcomes in this population. Therefore, researchers sought to examine economic independence in a Norwegian national cohort of cancer survivors diagnosed at a young age.

For the study, investigators analyzed data from 1,212,013 individuals born in Norway between 1965 and 1985, of which 5440 had been diagnosed with cancer before age 25. Follow-up data was examined through 2007.

Results showed that cancer survivors were more likely to receive government financial assistance (men: hazard ratio [HR], 1.4; 95% CI, 1.3-1.5; women: HR, 1.5; 95% CI, 1.3-1.6) and had a higher risk of not being employed (men: HR, 1.4; 95% CI, 1.2-1.7; women: HR, 1.4; 95% CI, 1.2-1.6) compared with those without cancer.

Investigators found that survivors of central nervous system malignancies had particularly pronounced discrepancies in income.

However, there was only a small difference in representation in higher skilled occupations for most employed survivors compared with those without cancer.

These findings may help to understand how a cancer diagnosis at a young age impacts subsequent job market outcomes.


Gunnes MW, Lie RT, Bjorge T, et al. Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study. Cancer. 2016 Aug 12. doi: 10.1002/cncr.30253. [Epub ahead of print]
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs